Deutsche Bank Maintains a 'Buy' on Medicis (MRX) Post Meeting with Management at Company HQ

Deutsche Bank maintains a 'Buy' on Medicis (NYSE: MRX), PT increased from $36 to $40.

Deutsche analyst says, "On Tuesday, we hosted an in-depth meeting with Medicis management which included a detailed look at the company’s key marketed products, development pipeline, business development activities, and growth outlook. Given our positive bias post this company visit in tandem with the recent improvement in Solodyn’s outlook following the critical settlement with Teva (Nasdaq: TEVA), we continue to rate Medicis shares Buy."

For more ratings news on Medicis click here and for the rating history of Medicis click here.

Shares of Medicis closed at $34.27 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Marex Group PLC (MRX) PT Raised to $90 at Keefe, Bruyette & Woods
• Intuitive Machines Inc. (LUNR) PT Lowered to $32 at Cantor Fitzgerald, Reaffirms Overweight Rating
• Powell Industries (POWL) PT Lowered to $235 at Cantor Fitzgerald